To analyze the therapeutic effect of tacrolimus Capsule on patients with chronic glomerulonephritis. Methods: 50 patients with Chronic Glomerulonephritis Treated in our hospital were randomly divided into control grou...To analyze the therapeutic effect of tacrolimus Capsule on patients with chronic glomerulonephritis. Methods: 50 patients with Chronic Glomerulonephritis Treated in our hospital were randomly divided into control group and observation group. The control group was treated with angiotensin converting enzyme inhibitor, and the observation group was treated with tacrolimus capsule on the basis of the control group. The treatment effects of the two groups were counted. Results: the therapeutic effect of the observation group was better than that of the control group (P < 0.05).Conclusion: in the process of clinical treatment of chronic glomerulonephritis, angiotensin converting enzyme inhibitor and tacrolimus capsule can be used for combined treatment, which can not only improve the renal function of patients, but also provide patients with high-quality treatment and improve their clinical symptoms while protecting their immunity. In the process of treatment, reduce the incidence of adverse reactions, improve patients' quality of life and improve patients' cognition of treatment work. In the process of treatment, the treatment scheme matching the clinical symptoms of patients should be formulated in combination with the clinical symptoms of patients, so as to improve the treatment quality of patients. It is recommended to promote it in a wide range of clinical practice.展开更多
文摘To analyze the therapeutic effect of tacrolimus Capsule on patients with chronic glomerulonephritis. Methods: 50 patients with Chronic Glomerulonephritis Treated in our hospital were randomly divided into control group and observation group. The control group was treated with angiotensin converting enzyme inhibitor, and the observation group was treated with tacrolimus capsule on the basis of the control group. The treatment effects of the two groups were counted. Results: the therapeutic effect of the observation group was better than that of the control group (P < 0.05).Conclusion: in the process of clinical treatment of chronic glomerulonephritis, angiotensin converting enzyme inhibitor and tacrolimus capsule can be used for combined treatment, which can not only improve the renal function of patients, but also provide patients with high-quality treatment and improve their clinical symptoms while protecting their immunity. In the process of treatment, reduce the incidence of adverse reactions, improve patients' quality of life and improve patients' cognition of treatment work. In the process of treatment, the treatment scheme matching the clinical symptoms of patients should be formulated in combination with the clinical symptoms of patients, so as to improve the treatment quality of patients. It is recommended to promote it in a wide range of clinical practice.
